Helix BioMedix, Inc. (HXBM)

Market Cap	606.71K -95.1%
Revenue (ttm)	2.07M +14.6%
Net Income	-2.58M
EPS	-15.59
Shares Out	224.71K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	600
Average Volume	281
Open	2.700
Previous Close	n/a
Day's Range	2.700 - 2.980
52-Week Range	1.750 - 7.190
Beta	0.63
RSI	22.99
Earnings Date	n/a

About Helix BioMedix

Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company was founded in 1988 and is based in Bothell, Washington.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 8
• Stock Exchange: OTCMKTS
• Ticker Symbol: HXBM

Financial Performance

In 2011, Helix BioMedix's revenue was $1.89 million, an increase of 122.07% compared to the previous year's $851,683. Losses were -$2.49 million, -67.73% less than in 2010.